Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunter Schuch

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|December 25, 2009
Severe aplastic anaemia following leflunomide therapyMirjam Wüsthof, Anna Smirnova, Ulrike Bacher, et al.
Onkologie|December 18, 2009
Single-center management of 136 patients with cancer of unknown primary site (CUP syndrome) over a period of 10 yearsIna Thöm, Claudia Rogers, Birte Andritzky, et al.
Anticancer Research|April 3, 2014
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell linesEmilia Nitsch, Sormeh Mina, Ingo Brammer, et al.
Biochemical and Biophysical Research Communications|May 1, 2007
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitroSonja Loges, Martin Butzal, Jasmin Otten, et al.
Cancer Letters|August 21, 2012
The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculatureLeticia Oliveira-Ferrer, Jasmin Wellbrock, Melanie Braig, et al.
Cancer|June 22, 2010
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancerIna Thöm, Birte Andritzky, Gunter Schuch, et al.
Investigational New Drugs|September 29, 2009
TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesisAlexander Schultze, Sebastian Decker, Jasmin Otten, et al.
Cancer Research|December 18, 2003
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cellsGunter Schuch, John V Heymach, Masashi Nomi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416Gunter Schuch, Maike de Wit, Jan Höltje, et al.
Molecular Cancer|November 22, 2013
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathwayLeticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|December 25, 2009
Severe aplastic anaemia following leflunomide therapyMirjam Wüsthof, Anna Smirnova, Ulrike Bacher, et al.
Onkologie|December 18, 2009
Single-center management of 136 patients with cancer of unknown primary site (CUP syndrome) over a period of 10 yearsIna Thöm, Claudia Rogers, Birte Andritzky, et al.
Anticancer Research|April 3, 2014
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell linesEmilia Nitsch, Sormeh Mina, Ingo Brammer, et al.
Biochemical and Biophysical Research Communications|May 1, 2007
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitroSonja Loges, Martin Butzal, Jasmin Otten, et al.
Cancer Letters|August 21, 2012
The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculatureLeticia Oliveira-Ferrer, Jasmin Wellbrock, Melanie Braig, et al.
Cancer|June 22, 2010
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancerIna Thöm, Birte Andritzky, Gunter Schuch, et al.
Investigational New Drugs|September 29, 2009
TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesisAlexander Schultze, Sebastian Decker, Jasmin Otten, et al.
Cancer Research|December 18, 2003
Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cellsGunter Schuch, John V Heymach, Masashi Nomi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416Gunter Schuch, Maike de Wit, Jan Höltje, et al.
Molecular Cancer|November 22, 2013
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathwayLeticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, et al.
Pageof 5